Medicinova (MNOV) Capital Expenditures (2010 - 2025)
Medicinova (MNOV) posted quarterly Capital Expenditures of -$2.0 for Q4 2024, up 90.91% year-over-year from -$1.05 in Q1 2024, and down 133.33% quarter-over-quarter from $6.0 in Q3 2024.
Medicinova (MNOV) Capital Expenditures (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Capital Expenditures for 12 consecutive years, with -$2.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Capital Expenditures rose 90.91% year-over-year to -$2.0; the TTM figure through Dec 2025 stood at -$18.0 (down 100.66% YoY), while the FY2025 annual figure was $2899.0, up 223.91% from the prior year.
- Capital Expenditures eased to -$2.0 in Q4 2024 per MNOV's latest filing, from $6.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $32698.0 in Q4 2020 and bottomed at -$22.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $4684.0 across 4 years, with a median of $1190.0 in 2020.
- Annual changes were most pronounced in 2020 — Capital Expenditures soared 350.45% — and 2024, when it tumbled 99.78%.
- Medicinova's Capital Expenditures stood at $32698.0 in 2020, then plunged by 91.01% to $2938.0 in 2021, then slumped by 100.75% to -$22.0 in 2023, then jumped by 90.91% to -$2.0 in 2024.
- Business Quant data shows MNOV's Capital Expenditures at -$2.0 in Q4 2024, $6.0 in Q3 2024, and -$22.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,899.00 |
| Sep 30, 2025 | 2,899.00 |
| Dec 31, 2024 | -2.00 |
| Dec 31, 2024 | -2.00 |
| Sep 30, 2024 | 6.00 |
| Sep 30, 2024 | 6.00 |
| Dec 31, 2023 | -22.00 |
| Dec 31, 2023 | -22.00 |
| Sep 30, 2023 | 2,744.00 |
| Sep 30, 2023 | 2,744.00 |
| Sep 30, 2021 | 2,938.00 |
| Sep 30, 2021 | 2,938.00 |
| Dec 31, 2020 | 32,698.00 |
| Dec 31, 2020 | 32,698.00 |
| Sep 30, 2020 | 1,190.00 |
| Sep 30, 2020 | 1,190.00 |
| Jun 30, 2020 | 10.00 |
| Jun 30, 2020 | 10.00 |
| Mar 31, 2020 | 2,594.00 |
| Mar 31, 2020 | 2,594.00 |